U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07874269) titled 'MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke' on Oct. 08.
Brief Summary: This randomized, double-blind, controlled clinical trial evaluates the effectiveness and safety of combined mesenchymal stem cell (MSC) secretome and repetitive transcranial magnetic stimulation (rTMS) for motor recovery in patients with subacute ischemic stroke. Participants will be randomized to either an intervention group receiving intravenous MSC secretome combined with high-frequency ipsilesional rTMS or a control group receiving placebo infusion and sham rTMS. The intervention is administered once weekly for 8 weeks. The prima...